Skip Navigation


Human Molecular Genetics Advance Access originally published online on December 1, 2005
Human Molecular Genetics 2006 15(2):189-199; doi:10.1093/hmg/ddi426
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Material
Right arrow All Versions of this Article:
15/2/189    most recent
ddi426v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (24)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Weihl, C. C.
Right arrow Articles by Hanson, P. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weihl, C. C.
Right arrow Articles by Hanson, P. I.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation

Conrad C. Weihl1,2,*, Seema Dalal2, Alan Pestronk1 and Phyllis I. Hanson2

1Department of Neurology 2Department of Cell Biology and Physiology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, MO 63110, USA

* To whom correspondence should be addressed at: Department of Neurology, Washington University School of Medicine, PO Box 8111, 660 South Euclid Avenue, St Louis, MO 63110, USA. Tel: +1 3143626981; Fax: +1 3143623752; Email: weihlc{at}neuro.wustl.edu

Received September 24, 2005; Accepted November 12, 2005

Mutations in the AAA+ protein (ATPase associated with a variety of cellular activities) p97/VCP (valosin-containing protein) cause a dominantly inherited syndrome of inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia (IBMPFD). p97/VCP is a ubiquitously expressed protein that participates in a number of cellular processes including endoplasmic reticulum-associated degradation (ERAD). p97/VCP aids in the extraction of ubiquitinated proteins from the endoplasmic reticulum (ER) and facilitates their delivery to the proteasome. This study focusses on the effects of disease-associated p97/VCP mutations on this pathway. We show that p97/VCP containing the most prevalent IBMPFD-associated mutation, R155H, has normal ATPase activity and hexameric structure. However, when expressed in cultured cells, both this and a second IBMPFD-associated p97/VCP mutant increase the overall level of ubiquitin-conjugated proteins and specifically impair degradation of mutant {Delta}F508-CFTR handled by the ERAD pathway. These effects are similar to those previously described for an ATPase deficient p97/VCP mutant and suggest that IBMPFD mutations impair p97/VCP cellular function. In a subset of cells, IBMPFD mutations also promote formation of aggregates that contain p97/VCP, ubiquitin conjugates and ER-resident proteins. Undegraded mutant {Delta}F508-CFTR also accumulates in these aggregates. We conclude that IBMPFD mutations in p97/VCP disrupt ERAD and that this may contribute to the pathogenesis of IBMPFD.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C C Weihl, P Temiz, S E Miller, G Watts, C Smith, M Forman, P I Hanson, V Kimonis, and A Pestronk
TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia
J. Neurol. Neurosurg. Psychiatry, October 1, 2008; 79(10): 1186 - 1189.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. N. Hebert and M. Molinari
In and Out of the ER: Protein Folding, Quality Control, Degradation, and Related Human Diseases
Physiol Rev, October 1, 2007; 87(4): 1377 - 1408.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. L. Isaacson, V. E. Pye, P. Simpson, H. H. Meyer, X. Zhang, P. S. Freemont, and S. Matthews
Detailed Structural Insights into the p97-Npl4-Ufd1 Interface
J. Biol. Chem., July 20, 2007; 282(29): 21361 - 21369.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. C. Weihl, S. E. Miller, P. I. Hanson, and A. Pestronk
Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice
Hum. Mol. Genet., April 15, 2007; 16(8): 919 - 928.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Heubes and O. Stemmann
The AAA-ATPase p97-Ufd1-Npl4 is required for ERAD but not for spindle disassembly in Xenopus egg extracts
J. Cell Sci., April 15, 2007; 120(8): 1325 - 1329.
[Abstract] [Full Text] [PDF]


Home page
IBMS BoneKEyHome page
M. H. Helfrich, J. C. Crockett, L. J. Hocking, and F. P. Coxon
The Pathogenesis of Osteoclast Diseases: Some Knowns, but Still Many Unknowns
IBMS BoneKEy, February 1, 2007; 4(2): 61 - 77.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. U. Hubbers, C. S. Clemen, K. Kesper, A. Boddrich, A. Hofmann, O. Kamarainen, K. Tolksdorf, M. Stumpf, J. Reichelt, U. Roth, et al.
Pathological consequences of VCP mutations on human striated muscle
Brain, February 1, 2007; 130(2): 381 - 393.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
K. Talbot and O. Ansorge
Recent advances in the genetics of amyotrophic lateral sclerosis and frontotemporal dementia: common pathways in neurodegenerative disease
Hum. Mol. Genet., October 15, 2006; 15(suppl_2): R182 - R187.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Allen, A. Buchberger, and M. Bycroft
The PUB Domain Functions as a p97 Binding Module in Human Peptide N-Glycanase
J. Biol. Chem., September 1, 2006; 281(35): 25502 - 25508.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.